We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$809M
AUM Growth
-$38.3M
Cap. Flow
-$53.5M
Cap. Flow %
-6.62%
Top 10 Hldgs %
32.36%
Holding
146
New
7
Increased
49
Reduced
46
Closed
12

Sector Composition

Rank Sector Weight
1 Financials 14.13%
2 Healthcare 13.32%
3 Technology 10.85%
4 Consumer Staples 9.63%
5 Consumer Discretionary 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHR icon
26
Whirlpool
WHR
$2.39B
$15M 1.85%
89,968
+820
+0.9% +$145K
SKT icon
27
Tanger
SKT
$4.78B
$13.9M 1.72%
346,978
+7,338
+2% +$267K
CL icon
28
Colgate-Palmolive
CL
$73.6B
$13.7M 1.69%
187,032
+4,851
+3% +$345K
RMD icon
29
ResMed
RMD
$28.8B
$12.9M 1.6%
204,464
+1,395
+0.7% +$82.2K
IJR icon
30
iShares Core S&P Small-Cap ETF
IJR
$109B
$12.4M 1.54%
213,838
+5,666
+3% +$323K
UNP icon
31
Union Pacific
UNP
$176B
$12.2M 1.5%
139,583
+2,644
+2% +$224K
SLB icon
32
SLB Ltd
SLB
$69.4B
$12M 1.49%
152,200
+7,105
+5% +$545K
TFCFA
33
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$11.8M 1.46%
436,978
+13,469
+3% +$392K
SNY icon
34
Sanofi
SNY
$105B
$11.1M 1.37%
264,585
-27,016
-9% -$1.11M
EOG icon
35
EOG Resources
EOG
$75.1B
$10.9M 1.34%
130,473
+9,396
+8% +$753K
PCH
36
DELISTED
PotlatchDeltic
PCH
$10.5M 1.29%
307,279
+26,554
+9% +$899K
IBB icon
37
iShares Biotechnology ETF
IBB
$9.23B
$10.3M 1.28%
+120,432
New +$10.8M
BAC icon
38
Bank of America
BAC
$424B
$9.52M 1.18%
717,394
-20,168
-3% -$283K
NVS icon
39
Novartis
NVS
$285B
$9.35M 1.16%
126,509
-13,582
-10% -$938K
GS icon
40
Goldman Sachs
GS
$311B
$8.88M 1.1%
59,782
-1,910
-3% -$298K
GOOG icon
41
Alphabet (Google) Class C
GOOG
$4.29T
$8.04M 0.99%
232,300
+1,620
+0.7% +$58.2K
USMV icon
42
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$6.78M 0.84%
146,804
+9,781
+7% +$434K
BRK.A icon
43
Berkshire Hathaway Class A
BRK.A
$1.06T
$6.73M 0.83%
31
ILCB icon
44
iShares Morningstar US Equity ETF
ILCB
$1.26B
$5.88M 0.73%
191,624
-32,184
-14% -$973K
IWF icon
45
iShares Russell 1000 Growth ETF
IWF
$123B
$5.06M 0.63%
201,644
+10,868
+6% +$271K
PG icon
46
Procter & Gamble
PG
$347B
$5.03M 0.62%
59,368
-236
-0.4% -$19.4K
PIV
47
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
$4.96M 0.61%
199,930
+10,674
+6% +$265K
ITOT icon
48
iShares Core S&P Total US Stock Market ETF
ITOT
$93.6B
$4.93M 0.61%
103,584
+10,458
+11% +$493K
VIG icon
49
Vanguard Dividend Appreciation ETF
VIG
$110B
$3.4M 0.42%
40,807
-9,632
-19% -$787K
BX icon
50
Blackstone
BX
$151B
$3.24M 0.4%
132,172

Similar funds

Crestwood Advisors Group's Q2 2016 Portfolio in Review

As of Q2 2016, Crestwood Advisors Group held 146 positions worth $809M, down 4.5% from $848M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Crestwood Advisors Group withdrew a net $53.5M in Q2 2016, closing 12 positions and reducing 46 holdings. Its most notable exit was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $21.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Crestwood Advisors Group opened a new position in iShares Biotechnology ETF worth $10.3M.

  • Crestwood Advisors Group's largest Q2 2016 buy was iShares Biotechnology ETF: 120,432 shares worth $10.3M.
  • Crestwood Advisors Group added most to iShares Core MSCI EAFE ETF in Q2 2016, an estimated $2.92M increase.
  • Crestwood Advisors Group's biggest Q2 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $5.6M.
  • Crestwood Advisors Group fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2016, selling an estimated $21.5M.
  • Crestwood Advisors Group's ten largest holdings make up 32% of its $809M portfolio in Q2 2016.
  • Crestwood Advisors Group opened 7 new positions and closed 12 in Q2 2016.
  • Crestwood Advisors Group's portfolio value fell 4.5% quarter-over-quarter to $809M.

Based on Crestwood Advisors Group's 13F filing for Q2 2016, filed 15 Aug 2016.